A Randomised, Double-Blind, Placebo-Controlled, Parallel-group, Multicentre, 24-week Study to Evaluate the Efficacy and Safety of Transdermal Testosterone (300 mcg/day) in Naturally Menopausal Women

Project: Research

StatusFinished
Effective start/end date1/06/071/06/08